Abstract:Background Transgender and gender diverse (TGD) individuals assigned female at birth (AFAB) often desire menstrual suppression due to dysphoria related to menses. Achieving amenorrhea may be more difficult in the setting of heavy menstrual bleeding (HMB) or a bleeding disorder (BD). The aim of this study was to investigate management patterns and rates of amenorrhea in TGD AFAB individuals with diagnoses of HMB and/or a BD. A secondary aim was to examine the influence of testosterone (T) on achieving amenorrhea. Methods A retrospective chart review was performed at a single academic center. IRB exemption was obtained. AFAB patients aged 10-21 who identified as TGD and had a diagnosis of HMB and/or a BD were identified with ICD-10 codes and using an Electronic Medical Record Search Engine (EMERSE). Variables collected are listed in Tables 1 and 2. Data was analyzed using t-tests and chi-squared tests. Results 121 patients met inclusion criteria. 16 (13.9%) patients had a diagnosed BD. 54 (44.6%) patients had a history of anemia, and 63 (52.1%) had iron deficiency. Patients with a known BD achieved amenorrhea at similar rates to patients without (62.5% vs 65.7%, p=0.78), regardless of T use. Patients that identified as male were more likely to achieve amenorrhea than nonbinary patients or any non-male gender identity ((p = 0.003), p = 0.004) (Table 1). 31 (26.7%) patients achieved amenorrhea with the first medication prescribed. 82 (67.8%) used an estrogen-containing medication for menstrual suppression. 76 (62.8%) patients ever achieved amenorrhea with any combination of hormonal medication. Of patients who achieved amenorrhea, 63 (82.9%) achieved amenorrhea on a single agent, and 12 (15.8%) required 2 agents. The most common agent used that resulted in amenorrhea was continuous oral contraceptive pills (COCs), and the most common combination used to achieve amenorrhea was T and norethindrone acetate (NETA). 55 (45.5%) patients were prescribed T for gender affirmation, and 42 (77.8%) patients achieved amenorrhea during the study period while on T. (Table 2) Of the patients who achieved amenorrhea with T, 44.4% required the use of a second agent, most commonly NETA. Individuals who used T at any point achieved significantly higher rates of amenorrhea than those who did not use T (76.3% vs 43.9%, p<.001) . Conclusions BD diagnosis did not influence rates of amenorrhea, regardless of the use of T. TGD adolescents on T with HMB had lower rates of amenorrhea when compared to prior studies looking at all TGD individuals on T. In addition, almost half of the patients on T also required the use of a second agent to achieve amenorrhea.

Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic

Treatment Modalities in Adolescents Who Present with Heavy Menstrual Bleeding

Characteristics Associated with Annual Bleeding Frequency among Hemophilia Patients in the United States

PRO53 CLOTTING FACTOR UTILIZATION AND BLEEDING RATES AMONG PERSONS WITH HEMOPHILIA A FROM A LONGITUDINAL STUDY

Assessment of rare bleeding disorders in adolescents with heavy menstrual bleeding

Menstrual suppression to decrease intrauterine device expulsion in adolescents with inherited bleeding disorders

Intrauterine Device Outcomes in Young Women with Heavy Menstrual Bleeding: Comparing Patients with and without Inherited Bleeding Disorders

Knowledge and Confidence of Obstetrics and Gynecology Residents in the Evaluation and Management of Heavy Menstrual Bleeding Due to Inherited Bleeding Disorders

Prospective evaluation of ISTH‐BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic

Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study

Menstrual management in developmentally delayed adolescent females

108. Prevalence of bleeding disorders in adolescents presenting with heavy menstrual bleeding and anemia

The experience of girls and young Women with inherited bleeding disorders

80. Management of Heavy Menstrual Bleeding in Transgender and Gender Diverse Adolescents and Young Adults

Women and girls with inherited bleeding disorders: Focus on haemophilia carriers and heavy menstrual bleeding

53. Examining Menstrual Suppression Method Choice and Continuation Rates in Adolescents with Disabilities

109. Primary Care Referrals for Heavy Menstrual Bleeding in Adolescents: A Retrospective Chart Review

Gynaecological management of women with inherited bleeding disorders. A UK Haemophilia Centres Doctors' Organisation Guideline

Effects of management of heavy menstrual bleeding of patients undergoing haploidentical hematopoietic stem cell transplantation

Systematic review and meta-analysis of the etiology of heavy menstrual bleeding in 2,770 adolescent females

Driving improvement of diagnosis and awareness of heavy menstrual bleeding in women among physicians